Evidence map›Paper›PMID 32812219›Full record

ArticleThe Journal of comparative neurology2021

Retina-specific targeting of pericytes reveals structural diversity and enables control of capillary blood flow.

Elena Ivanova, Carlo Corona, Cyril G Eleftheriou, Paola Bianchimano, Botir T Sagdullaev

Open access · greenAbstract read
In one paragraph

Article in The Journal of comparative neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Reciprocal Inhibitions of HRP and REC in a Coculture System.Archives of ophthalmology and optometry · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elena IvanovaBurke Neurological Institute, White Plains, New York, USA.
Carlo CoronaBurke Neurological Institute, White Plains, New York, USA.
Cyril G EleftheriouBurke Neurological Institute, White Plains, New York, USA.
Paola BianchimanoBurke Neurological Institute, White Plains, New York, USA.
Botir T SagdullaevBurke Neurological Institute, White Plains, New York, USA.ORCID 0000-0002-0611-1479
Burke Medical Research Institute · USCornell University · US

Funding

Vascular control in diabetic retinopathyR01EY026576 · NEI · WINIFRED MASTERSON BURKE MED RES INST · PI SAGDULLAEV, BOTIR T. · 2016 to 2020
$2.9M
Mechanisms of Vision Loss in X-Linked Juvenile RetinoschisisR01EY029796 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI MCANANY, JAMES JASON, PEACHEY, NEAL S. · 2019 to 2022
$1.9M
NEI NIH HHS R01 EY026576NEI NIH HHS R01 EY029796
6 · The paper itself

Abstract

Pericytes are a unique class of mural cells essential for angiogenesis, maintenance of the vasculature and are key players in microvascular pathology. However, their diversity and specific roles are poorly understood, limiting our insight into vascular physiology and the ability to develop effective therapies. Here, in the mouse retina, a tractable model of the CNS, we evaluated distinct classes of mural cells along the vascular tree for both structural characterization and physiological manipulation of blood flow. To accomplish this, we first tested three inducible mural cell-specific mouse lines using a sensitive Ai14 reporter and tamoxifen application either by a systemic injection, or by local administration in the form of eye drops. The specificity and pattern of cre activation varied significantly across the three lines, under either the PDGFRβ or NG2 promoter (Pdgfrβ-CreRha, Pdgfrβ-CreCsln, and Cspg4-Cre). In particular, a mouse line with Cre under the NG2 promoter resulted in sparse TdTomato labeling of mural cells, allowing for an unambiguous characterization of anatomical features of individual sphincter cells and capillary pericytes. Furthermore, in one PDGFRβ line, we found that focal eye drop application of tamoxifen led to an exclusive Cre-activation in pericytes, without affecting arterial mural cells. We then used this approach to boost capillary blood flow by selective expression of Halorhodopsin, a highly precise hyperpolarizing optogenetic actuator. The ability to exclusively target capillary pericytes may prove a precise and potentially powerful tool to treat microcirculation deficits, a common pathology in numerous diseases.

Indexed as

Administration, OphthalmicAnimalsBlood Flow VelocityCapillariesMiceMice, TransgenicMicroscopy, Fluorescence, MultiphotonPericytesRegional Blood FlowRetinaTamoxifenTamoxifenHalorhodopsinmural cellsoptogeneticspericyteprecapillary sphincterretina

Identifiers

PMID32812219
PMCPMC7867582
OpenAlexW3054069117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.